Products
Co-DX PCR Home Testing Platform
PCR Home Covid-19 Test Kit
Co-DX Box
Diagnostic Solutions
Diagnostics Logix Smart Abc
Diagnostics Logix Smart COVID 19
Diagnostics Logix Smart MTB
Diagnostics Logix Smart SARS-CoV-2 DS
Diagnostics Logix Smart SARS-CoV-2 RdRpE
Diagnostics Logix Smart ZDC
Diagnostics Logix Smart Zika
Research Solutions
Research Logix Smart Abc RUO
Research Logix Smart COVID-19 RUO
Research Logix Smart Monkeypox RUO
Research Logix Smart Mpox (2-Gene) RUO
Research Logix Smart SARS-CoV-2 DS RUO
Research Logix Smart SARS-CoV-2 RUO
Maverick Blue® Nucleic Acid Stain
Vector Control Solutions
Vector Smart NAM-e
Vector Smart NAM-w
Vector Smart VZDC
Industries
Industry At Home
Industry Healthcare
Industry Laboratory
Industry Business Enterprise
Industry Vector Control
Technology
Real-Time PCR
Multiplexing
Co-Primers
About
Our Story
CoSara
Leadership
Scientific Advisory Board
Newsroom
Awards and Grants
Contact Us
Feedback
Resources
All Resources
Blog
News Articles
Publications
Events and Webcasts
Skip to content
123 Main Street, New York, NY 10001
123-456-7890
Top Navigation with Mega Menu
Products
Co-Dx™ PCR Pro™ Instrument
PCR Home COVID-19 Test
Co-Dx Box™
LABORATORY SOLUTIONS
Diagnostic Solutions
Logix Smart® ABC
Logix Smart® COVID-19 (FDA EUA)
Logix Smart® MTB
Logix Smart® SARS-CoV-2 (RdRp/E)
Logix Smart® SARS-CoV-2 (DS)
Logix Smart® ZDC (ZIKV-DENV-CHIKV)
Logix Smart® Zika Virus (ZIKV)
Research Solutions
Logix Smart® ABC (RUO)
Logix Smart® COVID-19 (RUO)
Logix Smart® Mpox (RUO)
Logix Smart® Mpox 2-Gene (RUO)
Logix Smart® SARS-CoV-2 (RUO)
Logix Smart® SARS-CoV-2 DS (RUO)
Maverick Blue® Nucleic Acid Stain
Vector Control Solutions
Vector Smart™ NAM-e
Vector Smart™ NAM-w
Vector Smart™ VZDC
Industries
Healthcare Professionals
Enterprise/Businesses
Laboratory Professionals
At Home Consumers
Vector Control Professionals
Technology
Real-Time PCR
Multiplexing
Co-Primers™
About
Our Story
CoSara
Leadership
Scientific Advisory Board
Awards and Grants
Contact
Feedback
Resources
All Resources
Blog
News Articles
Publications
Events and Webcasts
Search
Search
Search
Search
Investor Relations
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Year
All Years
2024
2023
2022
2021
2020
2019
2018
2017
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Oct 2, 2024
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3
Sep 24, 2024
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan
Sep 5, 2024
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test
Aug 15, 2024
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.
Aug 8, 2024
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results
Jul 29, 2024
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago
Jul 25, 2024
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast
Jul 2, 2024
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States
Jun 18, 2024
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Jun 14, 2024
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
May 9, 2024
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Apr 25, 2024
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Apr 24, 2024
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
Apr 12, 2024
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Apr 4, 2024
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
Mar 21, 2024
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address
Mar 18, 2024
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England
Mar 14, 2024
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
Mar 7, 2024
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
Feb 29, 2024
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast
Feb 1, 2024
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024
Jan 3, 2024
Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12
Dec 27, 2023
Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro
Nov 29, 2023
Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023
Nov 9, 2023
Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results
Show
5
10
25
50
100
per page
«
1
2
3
4
5
6
7
8
9
10
11
»
Join Our Newsletter
Receive our latest blog posts directly in your inbox!
Your email
Sign up now